Emvision Medical Devices Ltd (EMV) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Emvision Medical Devices Ltd (EMV) has a cash flow conversion efficiency ratio of -0.323x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-3.00 Million ≈ $-2.12 Million USD) by net assets (AU$9.28 Million ≈ $6.57 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Emvision Medical Devices Ltd - Cash Flow Conversion Efficiency Trend (2018–2025)
This chart illustrates how Emvision Medical Devices Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Emvision Medical Devices Ltd debt and liabilities for a breakdown of total debt and financial obligations.
Emvision Medical Devices Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Emvision Medical Devices Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Global Graphics PLC
BR:HYSG
|
0.061x |
|
Chime Ball Technology Co Ltd
TWO:1595
|
-0.018x |
|
NMP Acquisition Corp.
NASDAQ:NMP
|
-0.116x |
|
Amicorp FS (UK) PLC
LSE:AMIF
|
N/A |
|
Bank Qnb Indonesia Tbk
JK:BKSW
|
0.027x |
|
Moens Bank A/S
CO:MNBA
|
N/A |
|
Garuda Metalindo Tbk PT
JK:BOLT
|
-0.092x |
|
Silk Logistics Holdings Ltd
AU:SLH
|
0.381x |
Annual Cash Flow Conversion Efficiency for Emvision Medical Devices Ltd (2018–2025)
The table below shows the annual cash flow conversion efficiency of Emvision Medical Devices Ltd from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see Emvision Medical Devices Ltd (EMV) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$9.28 Million ≈ $6.57 Million |
AU$-7.84 Million ≈ $-5.54 Million |
-0.844x | -160.85% |
| 2024-06-30 | AU$18.52 Million ≈ $13.10 Million |
AU$-5.99 Million ≈ $-4.24 Million |
-0.324x | -298.43% |
| 2023-06-30 | AU$5.12 Million ≈ $3.62 Million |
AU$834.15K ≈ $590.22K |
0.163x | +130.53% |
| 2022-06-30 | AU$7.08 Million ≈ $5.01 Million |
AU$-3.78 Million ≈ $-2.68 Million |
-0.534x | -19.47% |
| 2021-06-30 | AU$10.05 Million ≈ $7.11 Million |
AU$-4.49 Million ≈ $-3.18 Million |
-0.447x | +24.14% |
| 2020-06-30 | AU$5.52 Million ≈ $3.91 Million |
AU$-3.26 Million ≈ $-2.30 Million |
-0.589x | -22.46% |
| 2019-06-30 | AU$4.60 Million ≈ $3.26 Million |
AU$-2.22 Million ≈ $-1.57 Million |
-0.481x | +9.42% |
| 2018-06-30 | AU$1.28 Million ≈ $905.05K |
AU$-679.59K ≈ $-480.85K |
-0.531x | -- |
About Emvision Medical Devices Ltd
EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. It offers non-invasive brain scanners, including emu Brain Scanner, a bedside device; and First Responder Brain Scanner, a device embedded in standard road and air ambulances to deliver pre-hospita… Read more